Home > Financial Ratios > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
EBIT Margin

    Back to All Ratios
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year EBIT Margin History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2013
   EBIT Margin(%) 14.0415.2615.44-18.9611.60

What is the latest EBIT Margin ratio of NATH BIOGENES (INDIA) ?

The latest EBIT Margin ratio of NATH BIOGENES (INDIA) is 14.04 based on Mar2025 Consolidated results.
Year EBIT Margin
Mar202514.04
Mar202415.26
Mar202315.44
Mar2022-18.96
Mar201311.60

How is EBIT Margin of NATH BIOGENES (INDIA) Trending?

Years EBIT Margin % Change
Mar2025 14.04
-7.99
Mar2024 15.26
-1.17
Mar2023 15.44
Positive
Mar2022 -18.96
Negative
Mar2013 11.6 -

Other Financial Ratios of NATH BIOGENES (INDIA)


Compare EBIT Margin ratio of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹313.8 Cr -4.9% -5.1% -23% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹12,458.1 Cr -6.5% -0.9% -30.1% Stock Analytics
KAVERI SEED COMPANY ₹5,415.0 Cr -8.7% -8.9% -0.5% Stock Analytics
VENKYS (INDIA) ₹2,056.5 Cr -3.1% -1% -31.3% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,379.9 Cr 1.3% -9.7% -25% Stock Analytics
INDO US BIOTECH ₹262.9 Cr -7.3% -12.2% -52.7% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

-4.9%

-5.1%

-23%

SENSEX

-2.7%

-0.5%

-5.3%


You may also like the below Video Courses